Systematic discovery of drug interaction mechanisms

Molecular Systems Biology

Volumn 11, Issue 4, 2015, Pages 1-9

  Chevereau, Guillaume ^a,b   Bollenbach, Tobias ^a  

^a INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

^b INSA DE STRASBOURG   (France)

Author keywords

antibiotics; drug combination design; drug interaction mechanisms; Escherichia coli; general principles of biological systems

Indexed keywords

ADENOSINE TRIPHOSPHATE; POLYSACCHARIDE; ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE; LIPOPOLYSACCHARIDE;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM MUTANT; BIOSYNTHESIS; CELL FUNCTION; COMBINATION CHEMOTHERAPY; CONCEPTUAL FRAMEWORK; DRUG INTERACTION; DRUG MECHANISM; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION; GENE ONTOLOGY; GROWTH RATE; MOLECULAR MECHANICS; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; COMBINATION DRUG THERAPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUTATION; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ADENOSINE TRIPHOSPHATE; ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ESCHERICHIA COLI; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; LIPOPOLYSACCHARIDES; MUTATION; POLYSACCHARIDES, BACTERIAL;

EID: 84928790670     PISSN: None     EISSN: 17444292     Source Type: Journal    
DOI: 10.15252/msb.20156098     Document Type: Article

References (34)

1. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H, (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2: 2006.0008
2. Balemans W, Vranckx L, Lounis N, Pop O, Guillemont J, Vergauwen K, Mol S, Gilissen R, Motte M, Lançois D, De Bolle M, Bonroy K, Lill H, Andries K, Bald D, Koul A, (2012) Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria. Antimicrob Agents Chemother 56: 4131-4139
3. Baltzer B, (1979) Degradation of mecillinam in aqueous solution. J Pharm Sci 68: 1207-1215
4. Bollenbach T, Quan S, Chait R, Kishony R, (2009) Nonoptimal microbial response to antibiotics underlies suppressive drug interactions. Cell 139: 707-718
5. Chait R, Craney A, Kishony R, (2007) Antibiotic interactions that select against resistance. Nature 446: 668-671
6. Cokol M, Chua HN, Tasan M, Mutlu B, Weinstein ZB, Suzuki Y, Nergiz ME, Costanzo M, Baryshnikova A, Giaever G, Nislow C, Myers CL, Andrews BJ, Boone C, Roth FP, (2011) Systematic exploration of synergistic drug pairs. Mol Syst Biol 7: 544
7. Du Q, Wang H, Xie J, (2011) Thiamin (vitamin B1) biosynthesis and regulation: a rich source of antimicrobial drug targets? Int J Biol Sci 7: 41-52
8. Evans CG, Chang L, Gestwicki JE, (2010) Heat shock protein 70 (hsp70) as an emerging drug target. J Med Chem 53: 4585-4602
9. Falconer SB, Czarny TL, Brown ED, (2011) Antibiotics as probes of biological complexity. Nat Chem Biol 7: 415-423
10. Hegreness M, Shoresh N, Damian D, Hartl D, Kishony R, (2008) Accelerated evolution of resistance in multidrug environments. Proc Natl Acad Sci USA 105: 13977-13981
11. Hillenmeyer ME, Fung E, Wildenhain J, Pierce SE, Hoon S, Lee W, Proctor M, St Onge RP, Tyers M, Koller D, Altman RB, Davis RW, Nislow C, Giaever G, (2008) The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320: 362-365
12. Jawetz E, Gunnison JB, (1953) Antibiotic synergism and antagonism; an assessment of the problem. Pharmacol Rev 5: 175-192
13. Keith CT, Borisy AA, Stockwell BR, (2005) Multicomponent therapeutics for networked systems. Nat Rev Drug Discov 4: 1-8
14. Keseler IM, Collado-Vides J, Gama-Castro S, Ingraham J, Paley S, Paulsen IT, Peralta-Gil M, Karp PD, (2005) EcoCyc: a comprehensive database resource for Escherichia coli. Nucleic Acids Res 33: D334-D337
15. Liu A, Tran L, Becket E, Lee K, Chinn L, Park E, Tran K, Miller JH, (2010) Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code. Antimicrob Agents Chemother 54: 1393-1403
16. Loewe S, (1928) Die quantitativen Probleme der Pharmakologie. Ergebnisse der Physiol. 27: 47-187
17. Moreau F, Desroy N, Genevard JM, Vongsouthi V, Gerusz V, Le Fralliec G, Oliveira C, Floquet S, Denis A, Escaich S, Wolf K, Busemann M, Aschenbrenner A, (2008) Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors. Bioorg Med Chem Lett 18: 4022-4026
18. Munck C, Gumpert HK, Wallin AIN, Wang HH, Sommer MO, (2014) Prediction of resistance development against drug combinations by collateral responses to component drugs. Sci Transl Med 6: 262ra156
19. Nichols RJ, Sen S, Choo YJ, Beltrao P, Zietek M, Chaba R, Lee S, Kazmierczak KM, Lee KJ, Wong A, Shales M, Lovett S, Winkler ME, Krogan NJ, Typas A, Gross CA, (2011) Phenotypic landscape of a bacterial cell. Cell 144: 143-156
20. Nikaido H, Vaara M, (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1-32
21. Ocampo PS, Lázár V, Papp B, Arnoldini M, Abel Zur Wiesch P, Busa-Fekete R, Fekete G, Pál C, Ackermann M, Bonhoeffer S, (2014) Antagonism is prevalent between bacteriostatic and bactericidal antibiotics. Antimicrob Agents Chemother 58: 4573-4582
22. Pena-Miller R, Laehnemann D, Jansen G, Fuentes-Hernandez A, Rosenstiel P, Schulenburg H, Beardmore R, (2013) When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biol 11: e1001540
23. Pillai SK, Moellering RC, Eliopoulos GM, (2005) Antimicrobial combinations. In Antibiotics in Laboratory Medicine, Lorian V, (ed), pp 365-440. Philadelphia: Lippincott Williams and Wilkins
24. Rodriguez de Evgrafov M, Gumpert H, Munck C, Thomsen TT, Sommer MO,. (2015) Collateral resistance and sensitivity modulate evolution of high-level resistance to drug combination treatment in Staphylococcus aureus. Mol Biol Evol 32: 1175-1185
25. Rothfield L, Pearlman-Kothencz M, (1969) Synthesis and assembly of bacterial membrane components: a lipopolysaccharide-phospholipid-protein complex excreted by living bacteria. J Mol Biol 44: 477-492
26. Schneider DA, Gaal T, Gourse RL, (2002) NTP-sensing by rRNA promoters in Escherichia coli is direct. Proc Natl Acad Sci USA 99: 8602-8607
27. Scott M, Hwa T, (2011) Bacterial growth laws and their applications. Curr Opin Biotechnol 22: 559-565
28. Tamae C, Liu A, Kim K, Sitz D, Hong J, Becket E, Bui A, Solaimani P, Tran KP, Yang H, Miller JH, (2008) Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli. J Bacteriol 190: 5981-5988
29. Tavazoie S, Hughes JD, Campbell MJ, Cho RJ, Church GM, (1999) Systematic determination of genetic network architecture. Nat Genet 22: 281-285
30. Waldstein E, Sharon R, Ben-Ishali R, (1974) Role of ATP in excision repair of ultraviolet radiation damage in Escherichia coli. Proc Natl Acad Sci USA 71: 2651-2654
31. Wood K, Nishida S, Sontag ED, Cluzel P, (2012) Mechanism-independent method for predicting response to multidrug combinations in bacteria. Proc Natl Acad Sci USA 109: 12254-12259
32. Wood KB, Wood KC, Nishida S, Cluzel P, (2014) Uncovering scaling laws to infer multidrug response of resistant microbes and cancer cells. Cell Rep 6: 1073-1084
33. Yeh P, Tschumi AI, Kishony R, (2006) Functional classification of drugs by properties of their pairwise interactions. Nat Genet 38: 489-494
34. Zaslaver A, Bren A, Ronen M, Itzkovitz S, (2006) A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat Methods 3: 623-628